Nalpropion Pharmaceuticals
Currax Pharmaceuticals is dedicated to providing innovative, life-changing medicines worldwide for patients with chronic, progressive diseases. Recognized as a Best Place to Work for three consecutive years, Currax emphasizes a culture of integrity, passion, accountability, and teamwork, aiming to make a positive impact on patients, employees, and the community.
Industries
Nr. of Employees
medium (51-250)
Nalpropion Pharmaceuticals
155 Franklin Road, Suite 450, Brentwood, TN 37027
Patents
Methods of providing weight loss therapy in patients with major depression
US-11033543-B2
View Details
Methods of providing weight loss therapy in patients with major depression
US-11033543-B2
View DetailsProducts
Oral extended-release combination for obesity (naltrexone HCl ER + bupropion HCl ER)
An oral extended-release combination formulation developed and commercialized for treatment of obesity; subject of ongoing clinical development and outcomes studies.
Breath-powered intranasal sumatriptan formulation for migraine
An intranasal, breath-powered sumatriptan delivery formulation in clinical development for adolescent migraine.
Branded and generic pharmaceutical portfolio
A distributed portfolio of branded and generic medicines spanning multiple therapeutic areas, supported by commercial and distribution operations.
Oral extended-release combination for obesity (naltrexone HCl ER + bupropion HCl ER)
An oral extended-release combination formulation developed and commercialized for treatment of obesity; subject of ongoing clinical development and outcomes studies.
Breath-powered intranasal sumatriptan formulation for migraine
An intranasal, breath-powered sumatriptan delivery formulation in clinical development for adolescent migraine.
Branded and generic pharmaceutical portfolio
A distributed portfolio of branded and generic medicines spanning multiple therapeutic areas, supported by commercial and distribution operations.
Services
Sponsor and operate interventional clinical trials across phases, including active Phase 4 outcomes studies and Phase 3 development programs.
Evaluation and funding support for investigator-initiated research and independent educational initiatives relevant to company products and therapeutic areas.
Channels for reporting suspected adverse reactions and safety events for marketed and investigational products.
Distribution and commercial support for a portfolio of branded and generic pharmaceutical products across therapeutic areas.
Sponsor and operate interventional clinical trials across phases, including active Phase 4 outcomes studies and Phase 3 development programs.
Evaluation and funding support for investigator-initiated research and independent educational initiatives relevant to company products and therapeutic areas.
Channels for reporting suspected adverse reactions and safety events for marketed and investigational products.
Distribution and commercial support for a portfolio of branded and generic pharmaceutical products across therapeutic areas.
Expertise Areas
- Clinical trial management
- Pharmacovigilance and drug safety
- GMP manufacturing and site qualification
- Regulatory compliance and submissions (FDA/EMA)
Key Technologies
- Clinical trial platforms and operations
- Real-world evidence analytics
- Pharmacovigilance reporting systems
- GMP manufacturing processes